BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  FDA Action Alert: Ortho Dermatologics/Valeant and scPharmaceuticals

  Monday, June 18, the agency will make a decision on Ortho Dermatologics’ New Drug Application (NDA) for IDP-118 lotion for plaque psoriasis. On June 13th, SCPharmaceuticals received a CRL for its Furoscix infusor.

  June 18, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  ObsEva Therapeutic Shows Reduction of Pain in Mid-Stage Endometriosis Trial

  Ernest Loumaye, chief executive officer of Switzerland-based ObsEva, is excited about the potential opportunity to provide women a significant treatment for endometriosis-associated pain.

  June 18, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  WindMIL Therapeutics Raises $32.53 Million

  WindMIL Therapeutics, based in Baltimore, Maryland, filed a form D with the U.S. Securities and Exchange Commission, indicating it had raised $32.53 million in equity financing.

  June 18, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Former Zacks Analyst Jason Napodano Will Spend 4 Months In Prison for Insider Trading Scheme

  A former biotech analyst who was charged with insider trading last fall will spend four months in prison this fall after pleading guilty to one count of securities fraud.

  June 18, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Cytokinetics’ Spinal Muscular Atrophy Drug Shows Promise in Phase II

  Cytokinetics released data from its Phase II clinical trial of reldesemtiv in patients with spinal muscular atrophy (SMA).

  June 18, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Lifts Clinical Hold on Solid Bio DMD Gene Therapy Trial: Shares Jump

  Shares of Solid Biosciences have jumped 11 percent in premarket trading after the company announced the U.S. Food and Drug Administration has lifted a clinical hold on the company’s Phase I/II clinical trial gene therapy treatment for Duchenne muscular dystrophy (DMD).

  June 18, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Places Clinical Hold on Ziopharma’s Sleeping Beauty CAR-T Therapy

  The U.S. Food and Drug Administration (FDA) placed a clinical hold on Boston-based Ziopharm Oncology’s Phase I trial of its Sleeping Beauty CAR-T therapy.

  June 18, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Evotec and Sanofi Sign Off on Three-Month-Old Infectious Disease Treatment Agreement

  Evotec is now a more powerful player in the infectious disease sector following the signing of its three-month-old deal to integrate Sanofi’s anti-infectives unit, including the majority of Sanofi’s infectious disease research portfolio and initiatives into its organization.

  June 18, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  PTC Therapeutics Presented Updated Interim Data from SMA Clinical Trial

  PTC Therapeutics presented updated interim clinical data from Part 1 of its FIREFISH clinical trial of risdiplam (RG7916) in babies with Type 1 Spinal Muscular Atrophy.

  June 18, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Top 5 Women Executives in the Biopharma Industry by Compensation

  Not only are women generally underrepresented in the biopharma industry, but compared to many of the top male executives, underpaid. Here’s a closer look at the top five female executives by pay in the biopharma industry.

  June 18, 2018

   · 

  4 min read

   · 

  Mark Terry